Clinical Trial Partnerships Leverage the INNOVATE trial and BrioVAD research footprint to engage top heart failure centers and KOLs, establish trial-site networks, provide clinician training, and generate early outcome data to support broader adoption and payer discussions.

Global Expansion Pursue regional partnerships and distributors in the US, China, and Europe to navigate regulatory requirements, optimize local reimbursement strategies, and accelerate market access and clinical adoption.

Value-Based Selling Develop a payer-focused value proposition grounded in health outcomes and potential cost savings to support reimbursement, formulary inclusion, and adoption within major heart failure programs.

Differentiated Technology Highlight BrioVAD LVAS unique design elements that improve blood flow and patient comfort, using this differentiation to win surgeon preference and speed program scale and trial enrollment.

Credibility and Growth Leverage BrioHealth’s growth narrative and upcoming public-market ambitions, plus industry conference activity, to attract strategic partnerships and procurement opportunities across global markets.